TransMedics

Levi & Korsinsky Announces Class Action Lawsuit Against TransMedics Group for Alleged Securities Fraud

by

New York, NY – Investors in TransMedics Group, Inc., a company traded under NASDAQ with the ticker symbol TMDX, have been alerted to a class action lawsuit spearheaded by the law firm Levi & Korsinsky, LLP. This legal action is focused on claims of alleged securities fraud affecting shareholders between February 28, 2023, and January 10, 2025. The lawsuit alleges that TransMedics was involved in various unethical and illegal practices to buoy its business and financial numbers, including the use of kickbacks and coercive tactics. There are also allegations of fraudulent overbilling and a general … Read more

Robbins Geller Rudman & Dowd LLP Announces Deadline for Investors in TransMedics Securities Litigation; Allegations of Kickbacks and Unsafe Practices Surface

by

SAN DIEGO — A class action lawsuit has been filed against TransMedics Group, Inc., a medical technology company specializing in organ transplant therapy for patients with end-stage organ failure. The complaint, handled by Robbins Geller Rudman & Dowd LLP, involves allegations of securities fraud. Individuals who purchased or acquired TransMedics securities between February 28, 2023, and January 10, 2025, are urged to seek appointment as lead plaintiff by April 15, 2025. The suit, formally titled Jewik v. TransMedics Group, Inc., and filed in the District Court of Massachusetts, accuses TransMedics and some of its executives … Read more